Table 3.
Correlation between VEGF expression and clinicopathological parameters in pancreatic cancer, n (%)
| Clinicopathological parameters | Cases (n) |
VEGF expression |
P value | |
| Positive | Negative | |||
| Age (yr) | ||||
| ≥ 70 | 24 | 17 (70.8) | 7 (29.2) | |
| < 70 | 38 | 20 (52.6) | 18 (47.4) | > 0.05 |
| Gender | ||||
| Male | 36 | 24 (66.7) | 12 (33.3) | |
| Female | 26 | 13 (50) | 13 (50) | > 0.05 |
| Differentiation | ||||
| Well | 17 | 10 (58.8) | 7 (41.2) | |
| Moderately | 15 | 8 (53.3) | 7 (46.7) | |
| Poorly | 30 | 19 (63.3) | 11 (36.7) | > 0.05 |
| Tumor size (cm) | ||||
| < 2.0 | 3 | 2 (66.7) | 1 (33.3) | |
| 2.0-4.0 | 38 | 21 (55.3) | 17 (44.7) | |
| > 4.0 | 21 | 14 (66.7) | 7 (33.3) | > 0.05 |
| Lymph node metastasis | ||||
| (-) | 13 | 7 (53.8) | 6 (46.2) | |
| (+) | 49 | 30 (61.2) | 19 (38.8) | > 0.05 |
| Distant metastasis | ||||
| (-) | 39 | 24 (61.5) | 15 (38.5) | |
| (+) | 23 | 13 (56.5) | 10 (43.5) | > 0.05 |
| NM stage | ||||
| I + II | 30 | 17 (56.7) | 13 (43.3) | |
| III + IV | 32 | 20 (62.5) | 12 (37.5) | > 0.05 |
Significance was estimated with χ2 test.